American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: American Psychiatric Association; 2013.
Zhang-Nunes SX, Maat-Schieman ML, van Duinen SG, Roos RA, Frosch MP, Greenberg SM. The cerebral beta-amyloid angiopathies: hereditary and sporadic. Brain Pathol. 2006 Jan. 16(1):30-9. [QxMD MEDLINE Link].
Schmidtke K, Hull M. Cerebral small vessel disease: how does it progress?. J Neurol Sci. 2005 Mar 15. 229-230:13-20. [QxMD MEDLINE Link].
Jellinger KA. The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathol (Berl). 2007 Apr. 113(4):349-88. [QxMD MEDLINE Link].
Delano-Wood L, Abeles N, Sacco JM, Wierenga CE, Horne NR, Bozoki A. Regional white matter pathology in mild cognitive impairment: differential influence of lesion type on neuropsychological functioning. Stroke. 2008 Mar. 39(3):794-9. [QxMD MEDLINE Link].
Jurasic MJ, Popovic IM, Morovic S, Trkanjec Z, Seric V, Demarin V. Can beta stiffness index be proposed as risk factor for dementia?. Journal of Neurological Sciences. In press:
Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997 Mar 12. 277(10):813-7. [QxMD MEDLINE Link].
Roman GC, Kalaria RN. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol Aging. 2006 Dec. 27(12):1769-85. [QxMD MEDLINE Link].
Brodaty H, McGilchrist C, Harris L, Peters KE. Time until institutionalization and death in patients with dementia. Role of caregiver training and risk factors. Arch Neurol. 1993 Jun. 50(6):643-50. [QxMD MEDLINE Link].
Brunnstrom HR, Englund EM. Cause of death in patients with dementia disorders. Eur J Neurol. 2009 Apr. 16(4):488-92. [QxMD MEDLINE Link].
Phelan EA, Borson S, Grothaus L, Balch S, Larson EB. Association of incident dementia with hospitalizations. JAMA. 2012 Jan 11. 307(2):165-72. [QxMD MEDLINE Link].
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov. 12(3):189-98. [QxMD MEDLINE Link].
Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. Apr 1983. 17:37-49.
Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell Scale for Depression in Dementia. Biol Psychiatry. 1988 Feb 1. 23(3):271-84. [QxMD MEDLINE Link].
Schneider B, Maurer K, Frolich L. [Dementia and suicide]. Fortschr Neurol Psychiatr. 2001 Apr. 69(4):164-9. [QxMD MEDLINE Link].
Price CC, Jefferson AL, Merino JG, Heilman KM, Libon DJ. Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data. Neurology. 2005 Aug 9. 65(3):376-82. [QxMD MEDLINE Link]. [Full Text].
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov. 12 (3):189-98. [QxMD MEDLINE Link].
Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ. Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology. June 11, 2002. 58(11):1629-34. [QxMD MEDLINE Link].
Rusanen M, Kivipelto M, Quesenberry CP Jr, Zhou J, Whitmer RA. Heavy Smoking in Midlife and Long-term Risk of Alzheimer Disease and Vascular Dementia. Arch Intern Med. 2010 Oct 25. [QxMD MEDLINE Link].
Roman GC. The epidemiology of vascular dementia. Handbook of Clinical Neurology. 2008. vol. 89(3rd series):639-658.
Nagata K, Maruya H, Yuya H, et al. Can PET data differentiate Alzheimer's disease from vascular dementia?. Ann N Y Acad Sci. 2000 Apr. 903:252-61. [QxMD MEDLINE Link].
Starkstein SE, Sabe L, Vazquez S, et al. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease. Stroke. 1996 Mar. 27(3):408-14. [QxMD MEDLINE Link].
Amenta F, Lanari A, Mignini F, Silvestrelli G, Traini E, Tomassoni D. Nicardipine use in cerebrovascular disease: A review of controlled clinical studies. Journal of the Neurological Sciences. In press:
Seitz DP, Adunuri N, Gill SS, et al. Antidepressants for agitation and psychosis in dementia. Cochrane Database Syst Rev. 2011 Feb 16. 2:CD008191. [QxMD MEDLINE Link].
McNamara D. Physical Fitness Tied to a Nearly 90% Reduction in Dementia Risk. Medscape Medical News. Available at https://www.medscape.com/viewarticle/894032. March 16, 2018; Accessed: March 27, 2018.
Hörder H, Johansson L, Guo X, Grimby G, Kern S, Östling S, et al. Midlife cardiovascular fitness and dementia: A 44-year longitudinal population study in women. Neurology. 2018 Mar 14. [QxMD MEDLINE Link].
Schwarzinger M, Pollock BG, Hasan OSM, Dufouil C, Rehm J, QalyDays Study Group. Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study. Lancet Public Health. 2018 Mar. 3 (3):e124-e132. [QxMD MEDLINE Link].
Meeuwsen EJ, Melis RJ, Van Der Aa GC, Golüke-Willemse GA, De Leest BJ, Van Raak FH, et al. Effectiveness of dementia follow-up care by memory clinics or general practitioners: randomised controlled trial. BMJ. 2012 May 15. 344:e3086. [QxMD MEDLINE Link]. [Full Text].
Vercambre MN, Grodstein F, Manson JE, Stampfer MJ, Kang JH. Physical activity and cognition in women with vascular conditions. Arch Intern Med. 2011 Jul 25. 171(14):1244-50. [QxMD MEDLINE Link]. [Full Text].
Shprecher D and Mehta L. The syndrome of delayed post- hypoxic leukoencephalopathy. Neurorehabilitation. 2010. 26:65-72.
American Psychiatric Association. Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. American Psychiatric Association. Am J Psychiatry. 1997 May. 154(5 Suppl):1-39. [QxMD MEDLINE Link].
Ballard C, McKeith I, O'Brien J, et al. Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes. Dement Geriatr Cogn Disord. 2000 Mar-Apr. 11(2):59-65. [QxMD MEDLINE Link].
Caplan LR. Binswanger's disease--revisited. Neurology. 1995 Apr. 45(4):626-33. [QxMD MEDLINE Link].
Chabriat H, Vahedi K, Iba-Zizen MT, et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet. 1995 Oct 7. 346(8980):934-9. [QxMD MEDLINE Link].
Chui HC. Vascular dementia, a new beginning: shifting focus from clinical phenotype to ischemic brain injury. Neurol Clin. 2001. 18:951-77.
Cummings JL. Vascular subcortical dementias: clinical aspects. Dementia. 1994 May-Aug. 5(3-4):177-80. [QxMD MEDLINE Link].
Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet. 2002 Apr 13. 359(9314):1283-90. [QxMD MEDLINE Link].
European Dementia Study. European Pentoxifylline Multi-Infarct Dementia Study. Eur Neurol. 1996. 36(5):315-21. [QxMD MEDLINE Link].
Fagerstrom KO. Reducing the weight gain after stopping smoking. Addict Behav. 1987. 12(1):91-3. [QxMD MEDLINE Link].
Grilli M, Pizzi M, Memo M, Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science. 1996 Nov 22. 274(5291):1383-5. [QxMD MEDLINE Link].
Hachinski VC, Bowler JV. Vascular dementia. Neurology. 1993 Oct. 43(10):2159-60; discussion 2160-1. [QxMD MEDLINE Link].
Hebert R, Brayne C. Epidemiology of vascular dementia. Neuroepidemiology. 1995. 14(5):240-57. [QxMD MEDLINE Link].
in't Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging. 2001 May-Jun. 22(3):407-12. [QxMD MEDLINE Link].
Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging. 2000 Mar-Apr. 21(2):321-30. [QxMD MEDLINE Link].
Kalmijn S, Launer LJ, Ott A, et al. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol. 1997 Nov. 42(5):776-82. [QxMD MEDLINE Link].
Meyer JS, Huang J, Chowdhury MH. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias. J Neurol Sci. 2007 Jun 15. 257(1-2):97-104. [QxMD MEDLINE Link].
Meyer JS, Rogers RL, McClintic K, et al. Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study. J Am Geriatr Soc. 1989 Jun. 37(6):549-55. [QxMD MEDLINE Link].
Moretti R, Torre P, Antonello RM. Rivastigmine in subcortical vascular dementia: a randomized, controlled, open 12-month study in 208 patients. Am J Alzheimers Dis Other Demen. 2003 Sep-Oct. 18(5):265-72. [QxMD MEDLINE Link].
Moretti R, Torre P, Antonello RM, et al. Rivastigmine in vascular dementia. Expert Opin Pharmacother. 2004 Jun. 5(6):1399-410. [QxMD MEDLINE Link].
Nelson NW. Differential diagnosis of Alzheimer's dementia and vascular dementia. Dis Mon. 2007 Mar. 53(3):148-51. [QxMD MEDLINE Link].
Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol. 1996 Jun. 148(6):2083-95. [QxMD MEDLINE Link].
Sadowski M, Pankiewicz J, Scholtzova H, Li YS, Quartermain D, Duff K, et al. Links between the pathology of Alzheimer's disease and vascular dementia. Neurochem Res. 2004 Jun. 29(6):1257-66. [QxMD MEDLINE Link].
Skoog I. Status of risk factors for vascular dementia. Neuroepidemiology. 1998. 17(1):2-9. [QxMD MEDLINE Link].
Vascular Dementia Conference. Summary of the 1st International Conference on the Development of Drug Treatment for Vascular Dementia. Alzheimer Dis Assoc Disorders. Dec 1999. 13, Supplement 3:S1-S206.
Wetterling T, Kanitz RD, Borgis KJ. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke. 1996 Jan. 27(1):30-6. [QxMD MEDLINE Link].
Wilkinson D, Doody R, Helme R. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology. 2003 Aug 26. 61(4):479-86. [QxMD MEDLINE Link].